01 April 2025 : Clinical Research
Association of Sex with Survival and Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Experience in Türkiye
Melike Yüksel YavuzDOI: 10.12659/MSM.947817
Med Sci Monit 2025; 31:e947817
Table 1 Demographic data of the patients.
| Variables | All population | ||
|---|---|---|---|
| Age (year) Mean±SD | 64.3±8.5 | ||
| BMI (kg/m) Mean±SD | 25.5±4.9 | ||
| Smoking (package year) Mean±SD | 41.1±22.8 | ||
| Sex (N=100) | Men | 88 | 88.0 |
| Women | 12 | 12.0 | |
| Smoking (N=100) | Never smoker | 10 | 10.0 |
| Current smoker | 35 | 35.0 | |
| Former smoker | 55 | 55.0 | |
| Comorbidity (N=100) | No | 0 | 0.0 |
| Yes | 100 | 100.0 | |
| Hypertension (N=100) | No | 55 | 55.0 |
| Yes | 45 | 45.0 | |
| Diabetes mellitus (N=100) | No | 72 | 72.0 |
| Yes | 28 | 28.0 | |
| Coronary artery disease (N=100) | No | 80 | 80.0 |
| Yes | 20 | 20.0 | |
| Chronic heart failure (N=100) | No | 89 | 89.0 |
| Yes | 11 | 11.0 | |
| COPD (N=100) | No | 71 | 71.0 |
| Yes | 29 | 29.0 | |
| Asthma (N=100) | No | 97 | 97.0 |
| Yes | 3 | 3.0 | |
| Other (N=100) | No | 47 | 47.0 |
| Yes | 53 | 53.0 | |
| BMI – body mass index; COPD – chronic obstructive pulmonary disease. | |||






